Drug Eluting Stents Market Forecast to 2018 | It is expected to reach US$ 8,377.9 Mn by 2025 expanding at a CAGR of 5.67 % to 2025

Market Insights

The manufacturers actively involved in the production of drug eluting stents primarily focus on three important parameters which are; metal structure which is usually made of stainless steel or chromium cobalt alloy containing nickel which provides tensile strength and is non-leachable. The polymer which encapsulated the drug and controls its release at the site of implant to reduce local inflammation. The drug which is involved in the suppression of neointima hyperplasia. The cardiac surgeons while selecting a stent to achieve precise placement consider the dimensions of stents such as correct stent length matching the length of lesion, stent diameter matching diameter of the artery and sufficient deployment of stent to ensure full expansion of stent against the arterial wall to prevent adverse events such as restenosis and blood clots.

The inherent features of micro porous surface stents such as faster drug eluting rate and, higher drug loading capacity of the nanoporous surfaces are responsible for the polymer free coating stents dominating the product segment. The polymer based coating stents are in demand due to extended therapeutic efficacy and its smooth surface inhibiting the formation of neointima hyperplasia at the site of implant.

Full Report Visit: https://www.credenceresearch.com/report/drug-eluting-stents-market

The drug eluting stents market comprises of the major players which are Biotronik, Biosensors International Group, Abbott Laboratories, Inc., Boston Scientific Corporation, Cook Medical, Stentys, Medtronics Plc, Terumo Medical Corporation, Shandong JW Medical Systems and Lepu Medical Technology.

Key Market Movements:

• Rising prevalence of cardiovascular complications such as heart attack and stroke.
• Increasing public health awareness and enhanced government funding in establishing healthcare institutions with cardiac treatment centers
• Supportive regulatory environment for drug eluting stents products

Polymer based coating and polymer free coating has been included in the product segment. Polymer based coating is further sub segmented as non-biodegradable and biodegradable polymer based coatings. Polymer free coating comprises of micro porous surface, microstructured surface, slotted tubular surface and nanoporous surface. The application segment comprises of periphery artery disease and coronary artery disease. With respect to the scope of report market estimation and forecast for the duration 2015-2025 is included in the report.

Major countries showcasing the drug eluting stents market in their respective geographical regions are segmented as follows:

• North America
  • U.S.
  • Canada
• Europe
  • U.K.
  • Germany
  • Rest of Europe
• Asia Pacific
  • China
  • Japan
  • India
  • Rest of Asia Pacific
• Latin America
  • Mexico
  • Brazil
  • Rest of LATAM
• Middle East and Africa
  • GCC
  • Rest of Middle East and Africa

Market sizing and data forecast for the country cross sectional has been covered in the scope of the report.

For Sample Request: https://www.credenceresearch.com/sample-request/58866

Porter’s five forces model has been included in the scope of the report which give a holistic view regarding the market dynamics prevalent in the drug eluting stents market. Competitive landscape is a very useful study which gives insights regarding the competition faced by the major companies trying to gain a strong foothold in the drug eluting stents market.  The major players in global Drug Eluting Stents market are Stentys, Abbott Laboratories, Inc., Biosensors International Group, Biotronik, Boston Scientific Corporation, Cook Medical, Lepu Medical Technology, Medtronics Plc, Terumo Medical Corporation and Shandong JW Medical Systems.

Based on product, the global drug eluting stents market is categorized into

• Polymer Based Coating
  • Non-Biodegradable Polymer Based
  • Biodegradable Polymer Based
• Polymer Free Coating
  • Micro Porous Surface
  • Microstructured Surface
  • Slotted Tubular Surface
  • Nanoporous Surface

Atherosclerotic plaques comprises of cholesterol, fat, calcium and other inflammatory substances present in the blood usually builds up in the arteries. It is of prime importance to understand the fatal outcomes of untreated atherosclerotic plaques which may lead to stroke, heart attack, and death in severe cases. Polymer free coating stents shows market domination as it has faster drug elution rate. Microporous surface stent is gaining tremendous demand due to its reduction in the in-stent restenosis. Nanoporous surface has excellent features such as higher drug loading capacity and hence drives the polymer free coating stents market.

For the purpose of this study, the global drug eluting stents market is categorized into the following regional and country specific markets:

• North America
  • U.S.
  • Canada
• Europe
  • U.K.
  • Germany
  • Rest of Europe
• Asia Pacific
  • China
  • Japan
  • India
  • Rest of Asia Pacific
• Latin America
  • Brazil
  • Mexico
  • Rest of Latin America
• Middle East and Africa
  • GCC
  • Rest of Middle East and Africa

North American dominance is related to the rising prevalence of cardiovascular disease. The American Heart Association in its Heart Disease and Strokes Statistics 2017 has reported that cardiovascular disease is responsible for the deaths of around 800,000 U.S. citizens which is equivalent to one in every three deaths. Sedentary lifestyle, rising consumption of saturated food products contributes towards growth of North America drug eluting stents market. The European market is driven by the rising prevalence of type 2 diabetes and obesity. The presence of pharmaceutical companies manufacturing drug eluting stents represent Europe’s market growth for drug eluting stents. 

To Get Report Page: https://www.credenceresearch.com/report/drug-eluting-stents-market

Inquire Before Buying this Reports: https://www.credenceresearch.com/inquiry-before-buying/58866